Skip to content

Comparison of efficacy in treatment of dysmenorrhea between acupuncture and oral contraceptive pill: A randomized open-label controlled trial

Comparison of efficacy in treatment of dysmenorrhea between acupuncture and oral contraceptive pill: A randomized open-label controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003236
Enrollment
Unknown
Registered
2013-01-10
Start date
2013-01-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea

Interventions

combined oral contraceptive pill (COC):The assigned treatment regimen were 28 tablet pills per cycle containing 21 tablets of monophasic hormone (ethinyl estradiol (E2) 20 micrograms and desogestrel 1
acupuncture (ACU) group:The same standard protocol was used for every participants in the group consist of the six needling points per session that are Qi Hai, Zhongji and bilateral SanYinJiao and DiJ
acupuncture group (continue):The six sterile acupuncture needles “ShunHe” size 0.25x40 mm length 32x1.5 inches were pointed directly at each site with the depth of 1.0-1.5 chun without any stimulation

Sponsors

Faculty of Medicine Research Fund, Chiang Mai University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: - Dysmenorrhea history in at least the past three months; - Equal or more than grade 2 of verbal multidimentional scoring system for assessment of dysmenorrhea, which included three aspects: working ability, systemic symptoms and analgesic use; - Numeric rating scale of pain score equal or more than 5; - History of analgesic use.

Exclusion criteria

Exclusion criteria: - Having contraindication for combine oral contraceptive use + Deep vein thrombosis or pulmonary embolism, or a history thereof cerebrovascular accident (stroke), coronary artery or ischemic heart disease; + Structural heart disease, complicated by pulmonary hypertension, atrial fibrillation, or history of subacute bacterial endocarditis; + Diabetes with nephropathy, retinopathy, neuropathy, or other vascular disease; diabetes of more than 20 years duration; + Breast cancer; + Liver problems: benign hepatic adenoma or liver cancer, or history thereof; active viral hepatitis; severe cirrhosis; + Headaches (including migraine) with focal neurologic symptoms; + Major surgery with prolonged immobilization, or any surgery; + Patient older than 35 years and currently heavy smoker (20+/day); + Hypertension (160+/100+ mg Hg) or with vascular disease; + Pregnancy. - Having underlying gynecologic conditions associated with dysmenorrhea such as myoma uteri, endometrioma, ovarian tumor ruled out by transabdominal ultrasonography by a gynecologist; - Having bleeding tendency; - Having chronic pain syndrome.

Design outcomes

Primary

MeasureTime frame
Respond-er (decreasing numeric rating sclae more than 33%);Numbering Rating Scale;severity of dysmenorrhea;number of analgesic use;the quality of life score;complication;

Contacts

Public ContactINTIRA SRIPRASERT
intiras@yahoo.com+66-53-94-5553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026